Enjoy complimentary customisation on priority with our Enterprise License!
The rehabilitation robots market size is forecast to increase by USD 1.95 billion, at a CAGR of 27.15% between 2022 and 2027. The market's expansion hinges on various elements. Firstly, the escalating prevalence of strokes, injuries, and neurological diseases propels the demand for rehab services and products. This is further fueled by the increasing adoption of outpatient rehab, reflecting a shift towards patient-centric care models. Additionally, technological innovations play a pivotal role, offering advanced tools and therapies for effective rehab outcomes. These innovations encompass a wide range of solutions, from assistive devices to digital platforms, enhancing accessibility and customization in rehab programs. Overall, the market's growth trajectory is intertwined with the evolving landscape of healthcare, emphasizing the importance of tailored interventions and cutting-edge technologies in rehab services.
Furthermore, The major part of the revenue in North America will be contributed by the US. The country is likely to see an increase in investments in producing sophisticated rehabilitation robots that are cost-effective, lightweight, and user-friendly due to factors such as a large number of people with spinal cord injuries, traumatic brain injuries, stroke, multiple sclerosis, Parkinson's disease, and cerebral palsy and the rise in the number of rehabilitation centers in the country. Additionally, B Temia company offers rehabilitation robots such as Keeogo which is a SMART Powered Knee Orthosis that can enable people living with Neurological Conditions to walk freely and more safely. Also, Bionik Laboratories Corp. company offers rehabilitation robots with Burt robotic technology that accelerates recovery from paralysis or partial paralysis caused by stroke, TBI, and SBI.
Market Forecast 2023-2027
To learn more about this report, Request Free Sample
The market is witnessing growth driven by increasing per capita healthcare spending and the demand for technologically advanced equipment. With a rising geriatric population and prevalence of chronic diseases like spinal cord injury, there's a heightened need for therapy robots. Healthcare providers rely on these robots to deliver standard care hospitalization and specialized medical applications. However, stringent regulations ensure device reliability and user safety throughout the approval process and commercialization of products. Our researchers studied the market research and growth data for years, with 2022 as the base year and 2023 as the estimated year, and presented the key drivers, trends, and challenges for the market.
Technologically advanced sensors, batteries, actuators, control systems, and software, and advances in material technology and electrical and electronics engineering have helped companies to develop advanced exoskeletons and therapeutic rehabilitation robots. Robotic exoskeletons weigh as heavy as 20 kg, which is a key factor limiting their adoption. However, extensive investments are being made in R&D to develop lightweight exoskeletons. For instance, key companies have developed an ultra-low-power exoskeleton technology for robotic suits that enable anthropomorphic movements, thus eliminating the need for any external power source to operate the robot.
Moreover, market players are also focusing on improving the processing power of electronic components and portable control systems to enhance human-robot interaction (HRI). We expect research in exoskeletons to become a major trend in the global rehabilitation robots market during the forecast period. FES is a rehabilitation technique that uses low-energy currents to initiate a movement in the paralyzed part of the body by stimulating a connection between the paralyzed body part and the nervous system. FES has also been a key area of focus for companies.
The high price of exoskeletons is a major hindrance to the growth of the global rehabilitation robots market. However, with the increasing acceptance of exoskeletons as medical devices for treating conditions such as spinal cord injuries, strokes, and Parkinson's disease, proposals have been made to include health insurance coverage for exoskeletons. In countries such as Japan and Germany, treatments by rehabilitation robots are insured, thus reducing the cost to patients. This creates opportunities for companies to expand their customer base and generate more revenue.
For instance, in Germany, where the commercial use of HAL as a medical device is increasing, CYBERDYNE receives a treatment fee for each treatment session using HAL at no cost to the patient, as treatments are wholly covered by public workers compensation insurance. A similar initiative to include public health insurance coverage for treatment using HAL has begun in Japan. While the insurance in Germany will cover a treatment package of up to 60 treatment sessions, in Japan, the Ministry of Health, Labour, and Welfare ensures the treatment package as long as the treatment is effective.
A key challenge that is hindering the adoption of rehabilitation robots is their high selling price, which goes up to USD 100,000, as opposed to substitute products, which have an ASP of around USD 1,500. Apart from the high initial investment, costs of servicing, maintenance, training, and supervision add to the overall cost of ownership. Moreover, only a few companies are offering affordable rehabilitation robots as the technology is new. This makes the competition in the global rehabilitation robots market moderate and keeps the bargaining power of buyers low.
In addition, due to price sensitivity in developing countries, potential customers are more likely to opt for low-cost substitutes. This will be a major factor limiting market penetration in developing countries. Further, the focus should be on design and technical modifications that reduce the number of sensors, motor controllers, and encoders used in rehabilitation robots. Also, to increase the adoption of such robots, companies must continuously upgrade and optimize their products, conduct clinical trials, and expand their sales and distribution network.
In the market, the focus on older adults and their specific needs, coupled with the prevalence of conditions like stroke and musculoskeletal disorders, drives demand. Healthcare providers increasingly rely on therapy robots to address the needs of the geriatric population with chronic diseases. While the cost of rehabilitation robots and maintenance can be factors, stringent regulations ensure device reliability and user safety throughout the approval process for medical applications.
The market share growth by the UERR segment will be significant during the forecast period. A key driver of the market segment is the increase in the number of patients that need physical therapy, owing to the increase in the prevalence of stroke, which often leads to partial or complete paralysis, leading to loss of mobility. When a stroke affects an individual, the chances of upper-limb paralysis are much higher than lower-limb paralysis. Apart from strokes, upper limb paralysis can also happen due to sports injuries, occupational injuries, spinal cord injuries, or trauma. The demand for rehabilitation has increased over the years; however, therapy professionals are short in supply. Thus, rehabilitation robots are being increasingly adopted to restore the mobility of patients, therefore enabling them to perform activities of daily living (ADL) with minimal impact on their lives.
Customised Report as per your requirements!
The UERR segment showed a gradual increase in market share with 102.38 million in 2017. Robotic rehabilitation can serve patients in the absence or non-availability of clinical therapy and when long-term therapy is required. Rehabilitation robots give patients more time to recover and regain limb functions. These benefits are expected to lead to significant growth in the segment during the forecast period. With the growing acceptance and awareness of rehabilitation robots, more patients are expected to switch from conventional manual therapy to robotic rehabilitation.
Based on end-user, the market has been segmented into hospitals and clinics, senior care facilities, and homecare settings. The hospitals and clinics segment will account for the largest share of this segment.? The rising incidence of illnesses and ailments needing hospital-based treatment is contributing to the increased demand for rehabilitation robots in hospitals and clinics, driving further the growth of the market in focus during the forecast period. In addition, the need for intensive care hospitalizations is also being driven by factors such as an increase in the elderly population and a rise in the incidence of musculoskeletal disorders, strongly supported by the population increased disposable income. Which, in turn, further fuels the focused market expansion during the course of the forecast period. Thus, such offerings are expected to play an instrumental role in fueling the growth of the market segment of the market during the forecast period.
For more insights on the market share of various regions Download Sample PDF now!
North America is estimated to contribute 40% to the growth by 2027. Technavio's analysts have provided extensive insight into the market forecasting, detailing the regional trends and drivers influencing the market's trajectory throughout the forecast period. The US leads the world in the use of advanced technologies in almost every field. Healthcare is one such industry where the country spends more than double the global average. According to data from the Centers for Medicare and Medicaid Services (CMS), nearly half of the healthcare spending in the US is used for hospitals, clinics, and other facilities such as residential care homes. Rehabilitation robots are used in such facilities. Factors such as rising investments in advanced technologies to treat health conditions such as strokes and neurological diseases, the growth of the ageing population, high disposable income, and investments in medical science and healthcare drive the growth of the market in the region.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
We also have detailed analyses of the market’s competitive landscape and offer information on 20 market companies, including:
ABB Ltd., Boston Dynamics Inc., Cyberdyne Inc., DIH Hero, Diligent Robotics Inc., Ekso Bionics Holdings Inc., Focal Meditech, Fourier Intelligence, Hocoma AG, KUKA AG, MediTouch Ltd., MossRehab, Myomo Inc., Ottobock SE and Co. KGaA, Parker Hannifin Corp., Reha-Stim Medtec AG, ReWalk Robotics Ltd., Rex Bionics Ltd., Siemens AG, Tyromotion GmbH, and Barrett Technology
Technavio market forecast the an in-depth analysis of the market and its players through combined qualitative and quantitative data. The analysis classifies companies into categories based on their business approaches, including pure-play, category-focused, industry-focused, and diversified. Companies are specially categorized into dominant, leading, strong, tentative, and weak, based on their quantitative data analysis.
The market growth analysis report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2023-2027, as well as historical data from 2017 - 2021 for the following segments.
In the market, trainers play a crucial role in facilitating patient rehabilitation, adhering to ISO standards and regulations set by the European Commission. With increasing healthcare expenditure and surging awareness of robotic assistance, FDA approvals drive innovation. These robots address a spectrum of needs, from lower body disabilities rehabilitation for paralyzed patients to robotic lower-body exoskeletons aiding the aging population and frail elderly. They also cater to the robotic lower-body exoskeleton and lower body extremity due to upper body extremity rehabilitation, assisting those with neurological impairments and aiding post-stroke rehabilitation for individuals with musculoskeletal issues.
Market Scope |
|
Report Coverage |
Details |
Page number |
163 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 27.15% |
Market growth 2023-2027 |
USD 1.95 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
26.42 |
Regional analysis |
North America, Europe, APAC, South America, and Middle East and Africa |
Performing market contribution |
North America at 40% |
Key countries |
US, Japan, Germany, UK, and France |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
ABB Ltd., AlterG Inc., B Temia, Bionik Laboratories Corp., Boston Dynamics Inc., Cyberdyne Inc., DIH Hero, Diligent Robotics Inc., Ekso Bionics Holdings Inc., Focal Meditech, Fourier Intelligence, Hocoma AG, KUKA AG, MediTouch Ltd., MossRehab, Myomo Inc., Ottobock SE and Co. KGaA, Parker Hannifin Corp., Reha-Stim Medtec AG, ReWalk Robotics Ltd., Rex Bionics Ltd., Siemens AG, Tyromotion GmbH, and Barrett Technology |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.